Table 2.
Patient characteristics of all episodes of entero/rhinovirus infection and mono-infection of HRV-A, B and C.
| All episodes of entero/rhinovirus infection n (%) |
HRV-A mono-infection n (%) |
HRV-B mono-infection n (%) |
HRV-C mono-infection n (%) |
|
|---|---|---|---|---|
| Number | 204 | 41 (20.1) | 5 (2.5) | 76 (37.3) |
| Median age in years | 0.98 | 0.74 | 0.38 | 0.89 |
| Male gender | 129 (63.2) | 29 (70.7) | 3 (60) | 44 (57.9) |
| Site of infection | ||||
| URTI | 76 (37.3) | 14 (34.1) | 5 (100) | 28 (36.8) |
| Airway disease | 50 (24.5) | 11 (26.8) | 0 | 24 (31.5) |
| LRTI | 78 (38.2) | 16 (39) | 0 | 24 (31.6) |
| Severity | ||||
| Mild disease | 115 (56.4) | 26 (63.4) | 5 (100) | 41 (53.9) |
| Severe disease | 89 (43.6) | 15 (36.6) | 0 | 35 (46.1) |
| Deatha | 9 (4.4) | 2 (4.9) | 1 (20) | 2 (2.6) |
| Underlying risk factors | 136 (66.7) | 27 (65.9) | 1 (20) | 58 (76.3) |
| - Chronic respiratory diseases | 55 (27.0) | 12 (29.3) | 24 (31.6) | |
| - Asthma | 27 (13.2) | 6 (14.6) | 12 (15.8) | |
| - Chronic heart diseases | 48 (23.5) | 11 (26.8) | 19 (25) | |
| - Chronic neurological diseases | 26 (12.7) | 6 (14.6) | 1 (20) | 13 (17.1) |
| - Prematurity | 21 (10.3) | 5 (12.2) | 10 (13.2) | |
| - Immunocompromised | 13 (6.4) | 1 (2.4) | 3 (3.9) | |
| - Multiple risk factors | 44 (21.6) | 8 (19.5) | 20 (26.3) | |
a
Of the 5 deaths in HRV mono-infection without co-pathogens, HRV was considered as possibly responsible or contributory in only 2.